FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2344796392> ?p ?o ?g. }

• W2344796392 endingPage "88" @default.
• W2344796392 startingPage "83" @default.
• W2344796392 abstract "Several indices have been proposed to evaluate the systemic inflammatory response (SIR), which has been reported to be a useful prognostic factor in various types of cancer. We investigated the usefulness of the Glasgow Prognostic Score (GPS), neutrophil‑to‑lymphocyte ratio (NLR) and platelet‑to‑lymphocyte ratio (PLR) as prognostic factors in patients with advanced hepatocellular carcinoma (HCC) with extrahepatic metastasis (stage IVB). Between April, 1997 and March, 2013, a total of 434 HCC patients who developed extrahepatic metastasis were enrolled in the present study. The GPS was defined on the basis of pretreatment C‑reactive protein (CRP) and albumin (Alb) levels, and the subjects were grouped according to GPS 0‑2. The NLR was calculated as the neutrophil count̸lymphocyte count, and the PLR was calculated as the platelet count̸lymphocyte count. A comparative examination was performed using a survival analysis with approximate median values to determine the cut‑off value for both ratios. The median survival time (MST) of the 434 patients overall was 7.3 months, with cumulative survival rates of 31.8, 14.5 and 7.7% at 1, 2 and 3 years, respectively. The patient backround was as follows: The male:female ratio was 363:71, with a median age of 67.0 years (range, 15.0‑92.0 years). Hepatitis B virus patients:hepatitis C virus patients:non-B, non‑C hepatitis patients = 75:303:56. Child‑Pugh class A:B:C = 218:153:63. As regards T stage, ≤T2:T3:T4 = 60:190:181. The median white blood cell count was 4,650̸l (range, 1,400‑20,500̸l); the platelet count was 11.1x104̸µl (range, 3.1x104‑45.5x104̸µl); the aspartate aminotransferase level was 40.0 U̸l (range, 7.0‑338.0 U̸l) and the alanine aminotransferase level 64.5 U̸l (range, 16.0‑407.0 U̸l); the α‑fetoprotein level was 622.1 ng̸ml (range, 1.5‑3,311,794.0 ng̸ml); and the des-gamma-carboxyprothrombin level was 1,285.0 mAU̸ml (range, 8.0‑>75,000 mAU̸ml). The principal sites of metastasis included the lungs (53.9%), bone (38.9%), lymph nodes (21.4%) and adrenal glands (10.1%). The survival analysis revealed that hepatic functional reserve [Child‑Pugh class B+C; hazard ratio (HR)=2.055; 95% confidence interval (CI): 1.592‑2.651, P<0.001], T stage (T3; HR=2.359; 95% CI: 1.648‑3.376, P<0.001), AFP (≥200 ng̸ml; HR=1.416; 95% CI: 1.125‑1.783, P=0.003), NLR (≥3; HR=1.569; 95% CI: 1.253‑1.963, P<0.001) and GPS (1+2; HR=1.410; 95% CI: 1.060‑1.874, P=0.018) were independent risk factors. A total of 136 patients were included in the GPS 0 group, 169 patients in the GPS 1 group and 129 patients in the GPS 2 group. The low together with the high NLR groups comprised 217 patients. The MST was 480 days in the GPS 0 group, 154 days in the GPS 1 and 2 groups, 115 days in the high NLR group and 321 days in the low NLR group; a significant difference in survival was observed for the GPS and NLR groups. Therefore, we consider GPS and NLR to be useful prognostic factors in patients with stage IVB HCC." @default.
• W2344796392 created "2016-06-24" @default.
• W2344796392 creator A5006354271 @default.
• W2344796392 creator A5008443307 @default.
• W2344796392 creator A5013194037 @default.
• W2344796392 creator A5015914318 @default.
• W2344796392 creator A5028615687 @default.
• W2344796392 creator A5029365640 @default.
• W2344796392 creator A5037691579 @default.
• W2344796392 creator A5057606757 @default.
• W2344796392 creator A5074132164 @default.
• W2344796392 creator A5074219274 @default.
• W2344796392 creator A5086674791 @default.
• W2344796392 date "2016-04-28" @default.
• W2344796392 modified "2023-10-05" @default.
• W2344796392 title "The systemic inflammatory response as a prognostic factor for advanced hepatocellular carcinoma with extrahepatic metastasis" @default.
• W2344796392 cites W1560958285 @default.
• W2344796392 cites W1587807025 @default.
• W2344796392 cites W1922647212 @default.
• W2344796392 cites W1963697247 @default.
• W2344796392 cites W1964181833 @default.
• W2344796392 cites W1970761475 @default.
• W2344796392 cites W1971837077 @default.
• W2344796392 cites W1984052587 @default.
• W2344796392 cites W1986533360 @default.
• W2344796392 cites W1988902102 @default.
• W2344796392 cites W1990689816 @default.
• W2344796392 cites W1994193851 @default.
• W2344796392 cites W2002606672 @default.
• W2344796392 cites W2005041705 @default.
• W2344796392 cites W2010463369 @default.
• W2344796392 cites W2020830322 @default.
• W2344796392 cites W2042209473 @default.
• W2344796392 cites W2044640065 @default.
• W2344796392 cites W2066404804 @default.
• W2344796392 cites W2067692524 @default.
• W2344796392 cites W2071507111 @default.
• W2344796392 cites W2071520516 @default.
• W2344796392 cites W2079190859 @default.
• W2344796392 cites W2081871084 @default.
• W2344796392 cites W2094475660 @default.
• W2344796392 cites W2095075235 @default.
• W2344796392 cites W2099951919 @default.
• W2344796392 cites W2102240822 @default.
• W2344796392 cites W2111788806 @default.
• W2344796392 cites W2123105952 @default.
• W2344796392 cites W2136762063 @default.
• W2344796392 cites W2163403599 @default.
• W2344796392 doi "https://doi.org/10.3892/mco.2016.879" @default.
• W2344796392 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4906796" @default.
• W2344796392 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27330772" @default.
• W2344796392 hasPublicationYear "2016" @default.
• W2344796392 type Work @default.
• W2344796392 sameAs 2344796392 @default.
• W2344796392 citedByCount "30" @default.
• W2344796392 countsByYear W23447963922017 @default.
• W2344796392 countsByYear W23447963922018 @default.
• W2344796392 countsByYear W23447963922019 @default.
• W2344796392 countsByYear W23447963922020 @default.
• W2344796392 countsByYear W23447963922021 @default.
• W2344796392 countsByYear W23447963922022 @default.
• W2344796392 countsByYear W23447963922023 @default.
• W2344796392 crossrefType "journal-article" @default.
• W2344796392 hasAuthorship W2344796392A5006354271 @default.
• W2344796392 hasAuthorship W2344796392A5008443307 @default.
• W2344796392 hasAuthorship W2344796392A5013194037 @default.
• W2344796392 hasAuthorship W2344796392A5015914318 @default.
• W2344796392 hasAuthorship W2344796392A5028615687 @default.
• W2344796392 hasAuthorship W2344796392A5029365640 @default.
• W2344796392 hasAuthorship W2344796392A5037691579 @default.
• W2344796392 hasAuthorship W2344796392A5057606757 @default.
• W2344796392 hasAuthorship W2344796392A5074132164 @default.
• W2344796392 hasAuthorship W2344796392A5074219274 @default.
• W2344796392 hasAuthorship W2344796392A5086674791 @default.
• W2344796392 hasBestOaLocation W23447963921 @default.
• W2344796392 hasConcept C121608353 @default.
• W2344796392 hasConcept C126322002 @default.
• W2344796392 hasConcept C143998085 @default.
• W2344796392 hasConcept C146357865 @default.
• W2344796392 hasConcept C151730666 @default.
• W2344796392 hasConcept C2777063308 @default.
• W2344796392 hasConcept C2777761686 @default.
• W2344796392 hasConcept C2778019345 @default.
• W2344796392 hasConcept C2778488018 @default.
• W2344796392 hasConcept C2779013556 @default.
• W2344796392 hasConcept C2781018059 @default.
• W2344796392 hasConcept C29537977 @default.
• W2344796392 hasConcept C29730261 @default.
• W2344796392 hasConcept C71924100 @default.
• W2344796392 hasConcept C74133956 @default.
• W2344796392 hasConcept C86803240 @default.
• W2344796392 hasConcept C89560881 @default.
• W2344796392 hasConcept C90924648 @default.
• W2344796392 hasConceptScore W2344796392C121608353 @default.
• W2344796392 hasConceptScore W2344796392C126322002 @default.
• W2344796392 hasConceptScore W2344796392C143998085 @default.
• W2344796392 hasConceptScore W2344796392C146357865 @default.
• W2344796392 hasConceptScore W2344796392C151730666 @default.

• next